These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1172 related items for PubMed ID: 28783380

  • 1. Streptococcus pneumoniae serotype 19A: worldwide epidemiology.
    Isturiz R, Sings HL, Hilton B, Arguedas A, Reinert RR, Jodar L.
    Expert Rev Vaccines; 2017 Oct; 16(10):1007-1027. PubMed ID: 28783380
    [Abstract] [Full Text] [Related]

  • 2. The impact of pneumococcal conjugate vaccines on serotype 19A nasopharyngeal carriage.
    Tin Tin Htar M, Sings HL, Syrochkina M, Taysi B, Hilton B, Schmitt HJ, Gessner BD, Jodar L.
    Expert Rev Vaccines; 2019 Dec; 18(12):1243-1270. PubMed ID: 31587592
    [Abstract] [Full Text] [Related]

  • 3. The impact of routine childhood immunization with higher-valent pneumococcal conjugate vaccines on antimicrobial-resistant pneumococcal diseases and carriage: a systematic literature review.
    Tin Tin Htar M, van Den Biggelaar AHJ, Sings H, Ferreira G, Moffatt M, Hall-Murray C, Verstraeten T, Gessner BD, Schmitt HJ, Jodar L.
    Expert Rev Vaccines; 2019 Oct; 18(10):1069-1089. PubMed ID: 31585049
    [Abstract] [Full Text] [Related]

  • 4. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.
    Sharma D, Baughman W, Holst A, Thomas S, Jackson D, da Gloria Carvalho M, Beall B, Satola S, Jerris R, Jain S, Farley MM, Nuorti JP.
    Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290
    [Abstract] [Full Text] [Related]

  • 5. Pneumococcal serotype evolution in Western Europe.
    Tin Tin Htar M, Christopoulou D, Schmitt HJ.
    BMC Infect Dis; 2015 Oct 14; 15():419. PubMed ID: 26468008
    [Abstract] [Full Text] [Related]

  • 6. Pneumococcal serotype distribution in adults with invasive disease and in carrier children in Italy: Should we expect herd protection of adults through infants' vaccination?
    Azzari C, Cortimiglia M, Nieddu F, Moriondo M, Indolfi G, Mattei R, Zuliani M, Adriani B, Degl'Innocenti R, Consales G, Aquilini D, Bini G, Di Natale ME, Canessa C, Ricci S, de Vitis E, Mangone G, Bechini A, Bonanni P, Pasinato A, Resti M.
    Hum Vaccin Immunother; 2016 Oct 14; 12(2):344-50. PubMed ID: 26647277
    [Abstract] [Full Text] [Related]

  • 7. Effects of PCV10 and PCV13 on pneumococcal serotype 6C disease, carriage, and antimicrobial resistance.
    Grant LR, Hanquet G, Sepúlveda-Pachón IT, Theilacker C, Baay M, Slack MPE, Jodar L, Gessner BD.
    Vaccine; 2024 Apr 30; 42(12):2983-2993. PubMed ID: 38553292
    [Abstract] [Full Text] [Related]

  • 8. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S, Menzies R, Chiu C, Toms C, Blyth CC, Krause V, McIntyre P.
    Clin Infect Dis; 2017 Jan 15; 64(2):175-183. PubMed ID: 27986682
    [Abstract] [Full Text] [Related]

  • 9. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial.
    Dagan R, Patterson S, Juergens C, Greenberg D, Givon-Lavi N, Porat N, Gurtman A, Gruber WC, Scott DA.
    Clin Infect Dis; 2013 Oct 15; 57(7):952-62. PubMed ID: 23804191
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of a 3 + 0 pneumococcal conjugate vaccine schedule against invasive pneumococcal disease among a birth cohort of 1.4 million children in Australia.
    Gidding HF, McCallum L, Fathima P, Moore HC, Snelling TL, Blyth CC, Jayasinghe S, Giele C, de Klerk N, Andrews RM, McIntyre PB, ACIR linkage Investigator Team.
    Vaccine; 2018 May 03; 36(19):2650-2656. PubMed ID: 29627233
    [Abstract] [Full Text] [Related]

  • 11. Dynamic changes in paediatric invasive pneumococcal disease after sequential switches of conjugate vaccine in Belgium: a national retrospective observational study.
    Desmet S, Lagrou K, Wyndham-Thomas C, Braeye T, Verhaegen J, Maes P, Fieuws S, Peetermans WE, Blumental S.
    Lancet Infect Dis; 2021 Jan 03; 21(1):127-136. PubMed ID: 32702303
    [Abstract] [Full Text] [Related]

  • 12. Relationship between immune response to pneumococcal conjugate vaccines in infants and indirect protection after vaccine implementation.
    Dagan R.
    Expert Rev Vaccines; 2019 Jun 03; 18(6):641-661. PubMed ID: 31230486
    [Abstract] [Full Text] [Related]

  • 13. Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme.
    Wouters I, Van Heirstraeten L, Desmet S, Blaizot S, Verhaegen J, Goossens H, Van Damme P, Malhotra-Kumar S, Theeten H, NPcarriage Study Group.
    Vaccine; 2018 Jan 02; 36(1):15-22. PubMed ID: 29180027
    [Abstract] [Full Text] [Related]

  • 14. The rise and fall of pneumococcal serotypes carried in the PCV era.
    Devine VT, Cleary DW, Jefferies JM, Anderson R, Morris DE, Tuck AC, Gladstone RA, O'Doherty G, Kuruparan P, Bentley SD, Faust SN, Clarke SC.
    Vaccine; 2017 Mar 01; 35(9):1293-1298. PubMed ID: 28161425
    [Abstract] [Full Text] [Related]

  • 15. Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec.
    De Wals P, Lefebvre B, Deceuninck G, Longtin J.
    Vaccine; 2018 Jan 08; 36(3):421-426. PubMed ID: 29224962
    [Abstract] [Full Text] [Related]

  • 16. Persistent Circulation of Vaccine Serotypes and Serotype Replacement After 5 Years of Infant Immunization With 13-Valent Pneumococcal Conjugate Vaccine in the United Kingdom.
    Kandasamy R, Voysey M, Collins S, Berbers G, Robinson H, Noel I, Hughes H, Ndimah S, Gould K, Fry N, Sheppard C, Ladhani S, Snape MD, Hinds J, Pollard AJ.
    J Infect Dis; 2020 Mar 28; 221(8):1361-1370. PubMed ID: 31004136
    [Abstract] [Full Text] [Related]

  • 17. Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel.
    Ben-Shimol S, Givon-Lavi N, Greenberg D, Dagan R.
    Hum Vaccin Immunother; 2016 Mar 28; 12(2):268-76. PubMed ID: 26430921
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of Pneumococcal Conjugate Vaccines of Different Valences Against Invasive Pneumococcal Disease Among Children in Taiwan: A Nationwide Study.
    Su WJ, Lo HY, Chang CH, Chang LY, Chiu CH, Lee PI, Lu CY, Hsieh YC, Lai MS, Lin TY.
    Pediatr Infect Dis J; 2016 Apr 28; 35(4):e124-33. PubMed ID: 26974752
    [Abstract] [Full Text] [Related]

  • 19. CIRCULATING CLONAL COMPLEXES AND SEQUENCE TYPES OF STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A WORLDWIDE: THE IMPORTANCE OF MULTIDRUG RESISTANCE: A SYSTEMATIC LITERATURE REVIEW.
    Ruiz García Y, Nieto Guevara J, Izurieta P, Vojtek I, Ortega-Barría E, Guzman-Holst A.
    Expert Rev Vaccines; 2021 Jan 28; 20(1):45-57. PubMed ID: 33507135
    [Abstract] [Full Text] [Related]

  • 20. Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England.
    van Hoek AJ, Sheppard CL, Andrews NJ, Waight PA, Slack MP, Harrison TG, Ladhani SN, Miller E.
    Vaccine; 2014 Jul 23; 32(34):4349-55. PubMed ID: 24657717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.